CRSP shows severely deteriorating financial performance with operating cash flow burning 142% more cash despite revenue growth, while net losses widened 59% to $582M.
The massive increase in cash burn despite higher revenues indicates significant operational inefficiencies and unsustainable spending patterns that could threaten the company's ability to fund operations. While cash reserves increased to $348M, the accelerating burn rate of $345M annually suggests potential liquidity concerns within 12 months if trends continue.
Despite revenue growing 37% to $290M, CRSP's financial health deteriorated dramatically with net losses expanding 59% to $582M and operating cash burn more than doubling to $345M. Current liabilities surged 70% to $149M while R&D expenses only declined 11%, indicating poor cost management relative to the increased spending elsewhere. The combination of accelerating losses, massive cash burn, and rising short-term obligations creates a concerning financial trajectory that threatens near-term sustainability despite modest cash position improvements.
Operating cash flow fell 141.7% — earnings quality concerns; investigate working capital changes and non-cash items.
Current liabilities surged 69.9% — significant near-term obligations; verify ability to meet short-term debt.
Net income declined 58.8% — review whether driven by operations, interest costs, or non-recurring items.
Capex reduced 51.9% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Operating income deteriorated sharply — investigate whether driven by one-time charges or structural cost issues.
Strong top-line growth of 36.6% — accelerating demand or successful expansion into new markets.
Cash grew 16.5% — improving liquidity position supports investment and shareholder returns.
R&D spending cut 11.2% — could signal cost discipline or concerning reduction in innovation investment.
Liabilities increased 10.8% — monitor debt-to-equity ratio and interest coverage.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →